REDEFINING ALZHEIMER’S DISEASE THROUGH MODERN BIOTECHNOLOGY; FROM MOLECULAR PATHOGENESIS TO INNOVATIVE THERAPEUTICS AND DIAGNOSTIC FRONTIERS. JMHSR [Internet]. 2025 Dec. 25 [cited 2026 Mar. 23];2(4). Available from: https://jmhsr.info/index.php/jmhsr/article/view/1030